BiotechTube
Puresyn

Puresyn

Malvern, United States· Est.
puresyn.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Puresyn is a specialized CDMO focused exclusively on plasmid DNA manufacturing, a critical raw material for advanced cell and gene therapies like CAR-T and viral vector production. The company has built its reputation over decades on a foundation of proprietary purification resin (PolyFlo®), a flexible multi-grade product portfolio, and a strong emphasis on personalized client service. Operating from a 24,000 sq. ft. facility in Pennsylvania, Puresyn serves a global clientele of biopharma companies and academic institutions, supporting programs from research to late-phase clinical trials and commercialization. Its business model is entirely service-based, generating revenue through contract manufacturing and analytical testing services.

Drug Delivery

Technology Platform

Proprietary PolyFlo® chromatography resin for scalable, high-purity plasmid DNA purification, enabling a tiered product portfolio from research to cGMP grade.

Opportunities

The company is positioned to capitalize on the exponential growth of the cell and gene therapy market, which creates surging demand for high-quality plasmid DNA as a critical starting material.
Opportunities include expanding cGMP capacity for late-phase and commercial programs, and forming strategic partnerships with leading therapy developers.

Risk Factors

Key risks include intense competition from larger CDMOs and niche entrants, concentration risk from a reliance on a limited number of key clients, and execution risks associated with scaling manufacturing capacity while maintaining quality and personalized service.

Competitive Landscape

Puresyn competes in the specialized plasmid DNA CDMO space against larger, diversified CDMOs (e.g., Lonza, Thermo Fisher) and other focused players (e.g., Aldevron, VGXI). Its differentiation is based on deep expertise, proprietary purification technology, a flexible multi-grade offering, and a strong emphasis on personalized client collaboration.

More companies in CRISPR / Gene Editing →More companies in United States →